1. Home
  2. RLAY vs KFRC Comparison

RLAY vs KFRC Comparison

Compare RLAY & KFRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • KFRC
  • Stock Information
  • Founded
  • RLAY 2015
  • KFRC 1962
  • Country
  • RLAY United States
  • KFRC United States
  • Employees
  • RLAY N/A
  • KFRC N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • KFRC Professional Services
  • Sector
  • RLAY Health Care
  • KFRC Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • KFRC Nasdaq
  • Market Cap
  • RLAY 619.0M
  • KFRC 592.8M
  • IPO Year
  • RLAY 2020
  • KFRC 1995
  • Fundamental
  • Price
  • RLAY $3.99
  • KFRC $30.47
  • Analyst Decision
  • RLAY Strong Buy
  • KFRC Buy
  • Analyst Count
  • RLAY 13
  • KFRC 3
  • Target Price
  • RLAY $18.00
  • KFRC $52.33
  • AVG Volume (30 Days)
  • RLAY 1.2M
  • KFRC 281.4K
  • Earning Date
  • RLAY 11-05-2025
  • KFRC 10-27-2025
  • Dividend Yield
  • RLAY N/A
  • KFRC 5.12%
  • EPS Growth
  • RLAY N/A
  • KFRC N/A
  • EPS
  • RLAY N/A
  • KFRC 2.39
  • Revenue
  • RLAY $8,355,000.00
  • KFRC $1,361,445,000.00
  • Revenue This Year
  • RLAY $31.55
  • KFRC N/A
  • Revenue Next Year
  • RLAY N/A
  • KFRC $0.75
  • P/E Ratio
  • RLAY N/A
  • KFRC $12.76
  • Revenue Growth
  • RLAY N/A
  • KFRC N/A
  • 52 Week Low
  • RLAY $1.78
  • KFRC $29.33
  • 52 Week High
  • RLAY $8.32
  • KFRC $64.07
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 58.70
  • KFRC 39.70
  • Support Level
  • RLAY $3.87
  • KFRC $29.33
  • Resistance Level
  • RLAY $4.20
  • KFRC $31.36
  • Average True Range (ATR)
  • RLAY 0.21
  • KFRC 1.16
  • MACD
  • RLAY 0.03
  • KFRC 0.14
  • Stochastic Oscillator
  • RLAY 66.87
  • KFRC 28.36

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

Share on Social Networks: